Cited by 1,143Autoimmune Neurological Disorders and TreatmentsNeuroscience and Neuropharmacology ResearchPeripheral Neuropathies and Disorders

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

Open access
Hughes, Ethan G., Peng, Xiaoyu, Gleichman, Amy J., Lai, Meizan, Zhou, Lei, Tsou, Ryan, Parsons, Thomas D., Lynch, David R. +2 more·2010·The Journal of Neuroscience

Abstract

We recently described a severe, potentially lethal, but treatment-responsive encephalitis that associates with autoantibodies to the NMDA receptor (NMDAR) and results in behavioral symptoms similar to those obtained with models of genetic or pharmacologic attenuation of NMDAR function. Here, we demonstrate that patients' NMDAR antibodies cause a selective and reversible decrease in NMDAR surface density and synaptic localization that correlates with patients' antibody titers. The mechanism of this decrease is selective antibody-mediated capping and internalization of surface NMDARs, as Fab fragments prepared from patients' antibodies did not decrease surface receptor density, but subsequent cross-linking with anti-Fab antibodies recapitulated the decrease caused by intact patient NMDAR antibodies. Moreover, whole-cell patch-clamp recordings of miniature EPSCs in cultured rat hippocampal neurons showed that patients' antibodies specifically decreased synaptic NMDAR-mediated currents, without affecting AMPA receptor-mediated currents. In contrast to these profound effects on NMDARs, patients' antibodies did not alter the localization or expression of other glutamate receptors or synaptic proteins, number of synapses, dendritic spines, dendritic complexity, or cell survival. In addition, NMDAR density was dramatically reduced in the hippocampus of female Lewis rats infused with patients' antibodies, similar to the decrease observed in the hippocampus of autopsied patients. These studies establish the cellular mechanisms through which antibodies of patients with anti-NMDAR encephalitis cause a specific, titer-dependent, and reversible loss of NMDARs. The loss of this subtype of glutamate receptors eliminates NMDAR-mediated synaptic function, resulting in the learning, memory, and other behavioral deficits observed in patients with anti-NMDAR encephalitis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.0167-10.2010

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Experiments where patients' antibodies were added to cultures of hippocampal neurons or infused into the hippocampus of rodents showed specific antibody-mediated internalization of NMDAR and alteration of the mechanisms of synaptic plasticity.

    “Experiments where patients’ antibodies were added to cultures of hippocampal neurons or infused into the hippocampus of rodents showed specific antibody-mediated internalization of NMDAR and alteration of the mechanisms of synaptic plasticity.9, 10”

    From Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study (2013) · cites this paper as [9]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. Bailey K Identification of a street drug as N-ethyl-1-phenylcyclohexylamine, a phencyclidine analog J Pharm Sci 1978 67 885 886 660485
  2. Bergsman JB Krueger SR Fitzsimonds RM Automated criteria-based selection and analysis of fluorescent synaptic puncta J Neurosci Methods 2006 152 32 39 16198002
  3. Castellani S Giannini AJ Adams PM Physostigmine and haloperidol treatment of acute phencyclidine intoxication Am J Psychiatry 1982 139 508 510 7065301
  4. Chartoff EH Heusner CL Palmiter RD Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists Neuropsychopharmacology 2005 30 1324 1333 15688082
  5. Conti-Fine BM Milani M Kaminski HJ Myasthenia gravis: past, present, and future J Clin Invest 2006 116 2843 2854 17080188 PMC1626141
  6. Elmariah SB Crumling MA Parsons TD Balice-Gordon RJ Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses J Neurosci 2004 24 2380 2393 15014113 PMC6729485
  7. Elmariah SB Oh EJ Hughes EG Balice-Gordon RJ Astrocytes regulate inhibitory synapse formation via Trk-mediated modulation of postsynaptic GABAA receptors J Neurosci 2005 25 3638 3650 15814795 PMC6725365
  8. Florance NR Davis RL Lam C Szperka C Zhou L Ahmad S Campen CJ Moss H Peter N Gleichman AJ Glaser CA Lynch DR Rosenfeld MR Dalmau J Anti-NMDA receptor encephalitis in children and adolescents Ann Neurol 2009 DOI 10.1002/ana.21756, accepted article online PMC2826225 19670433 · DOI · Paper page
  9. Gunduz-Bruce H The acute effects of NMDA antagonism: from the rodent to the human brain Brain Res Rev 2009 60 279 286 18703087
  10. Haggerty GC Forney RB Johnson JM The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period Toxicol Appl Pharmacol 1984 75 444 453 6540902
  11. Hahn CG Wang HY Cho DS Talbot K Gur RE Berrettini WH Bakshi K Kamins J Borgmann-Winter KE Siegel SJ Gallop RJ Arnold SE Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia Nat Med 2006 12 824 828 16767099
  12. Hauser SL Waubant E Arnold DL Vollmer T Antel J Fox RJ Bar-Or A Panzara M Sarkar N Agarwal S Langer-Gould A Smith CH B-cell depletion with rituximab in relapsing-remitting multiple sclerosis N Engl J Med 2008 358 676 688 18272891
  13. Hestrin S Nicoll RA Perkel DJ Sah P Analysis of excitatory synaptic action in pyramidal cells using whole-cell recording from rat hippocampal slices J Physiol 1990 422 203 225 1972190 PMC1190128
  14. Iizuka T Sakai F Ide T Monzen T Yoshii S Iigaya M Suzuki K Lynch DR Suzuki N Hata T Dalmau J Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal Neurology 2008 70 504 511 17898324 PMC2586938
  15. Ishiura H Matsuda S Higashihara M Hasegawa M Hida A Hanajima R Yamamoto T Shimizu J Dalmau J Tsuji S Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab Neurology 2008 71 1921 1923 19047564
  16. Jentsch JD Roth RH The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 1999 20 201 225 10063482
  17. Krivosheya D Tapia L Levinson JN Huang K Kang Y Hines R Ting AK Craig AM Mei L Bamji SX El-Husseini A ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms J Biol Chem 2008 283 32944 32956 18819924 PMC5395083
  18. Luby ED Cohen BD Rosenbaum G Gottlieb JS Kelley R Study of a new schizophrenomimetic drug; sernyl AMA Arch Neurol Psychiatry 1959 81 363 369 13626287
  19. Mouri A Noda Y Noda A Nakamura T Tokura T Yura Y Nitta A Furukawa H Nabeshima T Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine Mol Pharmacol 2007 71 1598 1609 17344353
  20. Nagel A Engel AG Lang B Newsom-Davis J Fukuoka T Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation Ann Neurol 1988 24 552 558 2853605
  21. Olney JW Farber NB Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 1995 52 998 1007 7492260
  22. Sanders DB The Lambert-Eaton myasthenic syndrome Adv Neurol 2002 88 189 201 11908225
  23. Sansing LH Tuzun E Ko MW Baccon J Lynch DR Dalmau J A patient with encephalitis associated with NMDA receptor antibodies Nat Clin Pract Neurol 2007 3 291 296 17479076 PMC1936221
  24. Seki M Suzuki S Iizuka T Shimizu T Nihei Y Suzuki N Dalmau J Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis J Neurol Neurosurg Psychiatry 2008 79 324 326 18032452 PMC2574536
  25. Shepherd JD Huganir RL The cell biology of synaptic plasticity: AMPA receptor trafficking Annu Rev Cell Dev Biol 2007 23 613 643 17506699
  26. Titulaer MJ Wirtz PW Willems LN van Kralingen KW Smitt PA Verschuuren JJ Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome J Clin Oncol 2008 26 4276 4281 18779614
  27. Tuzun E Zhou L Baehring JM Bannykh S Rosenfeld MR Dalmau J Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma Acta Neuropathol 2009 PMC2888642 19680671
  28. Watt AJ van Rossum MC MacLeod KM Nelson SB Turrigiano GG Activity coregulates quantal AMPA and NMDA currents at neocortical synapses Neuron 2000 26 659 670 10896161
  29. Weiner AL Vieira L McKay CA Bayer MJ Ketamine abusers presenting to the emergency department: a case series J Emerg Med 2000 18 447 451 10802423
  30. Wirtz PW Bradshaw J Wintzen AR Verschuuren JJ Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families J Neurol 2004 251 1255 1259 15503107
  31. Wirtz PW Willcox N van der Slik AR Lang B Maddison P Koeleman BP Giphart MJ Wintzen AR Roep BO Verschuuren JJ HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome J Neuroimmunol 2005 159 230 237 15652424
  32. Yang Y Ge W Chen Y Zhang Z Shen W Wu C Poo M Duan S Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine Proc Natl Acad Sci U S A 2003 100 15194 15199 14638938 PMC299953

Cited by

Sorted by citations

Authors
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J.
Affiliations
  • University of Pennsylvania (US)
  • Children's Hospital of Philadelphia (US)
Venue
The Journal of Neuroscience
Published
2010-04-28
Volume
30
Issue
17
Pages
5866-5875
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2061056490
Cited by
1,143
References
6
Citations by year
2026: 47 · 2025: 61 · 2024: 82 · 2023: 66 · 2022: 83 · 2021: 60 · 2020: 80 · 2019: 87 · 2018: 69 · 2017: 80 · 2016: 95 · 2015: 84 · 2014: 72 · 2013: 63 · 2012: 58
FWCI
32.12
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (F31MH083395, MH057683, R56MH057683, MH083395, R01MH057683)
  • National Cancer Institute (CA 107192, CA89054, R01CA089054, R56CA089054, R01CA107192)
  • National Institute of Neurological Disorders and Stroke (NS 45986, R01NS046490, RC1NS068204, R01NS045986, F31NS056549, R56NS045986, NS046490, NS056549)
Topics
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
Keywords
anti-NMDA receptor encephalitis, NMDA receptor antibodies, receptor internalization, receptor capping, synaptic localization, miniature EPSCs, hippocampal neurons, AMPA receptors, glutamate receptors, antibody titers, behavioral deficits, autoimmune encephalitis
MeSH terms
Adolescent, Adult, Animals, Autoantibodies, Cells, Cultured, Child, Encephalitis, Female, Hippocampus, Humans, Immunoglobulin Fab Fragments, Rats, Inbred Lew, Receptor Aggregation, Synapses, Receptors, N-Methyl-D-Aspartate, Patch-Clamp Techniques, Excitatory Postsynaptic Potentials, Rats, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review